Exchange: NASDAQ·Updated 12:22 PM EDT

SBFM News

News
all
press releases
These Stocks are Lighting it Up
These names stand out for very different reasons: NeOnc Technologies (NASDAQ:NTHI), Hyperfine (NASDAQ:HYPR), bioAffinity Technologies (NASDAQ:BIAF), Profound Medical (NASDAQ:PROF), Wolfspeed (NYSE: WOLF) and Sunshine Biopharma (NASDAQ:SBFM).
24-7 Market News
These Stocks are Lighting it Up
These names stand out for very different reasons: NeOnc Technologies (NASDAQ:NTHI), Hyperfine (NASDAQ:HYPR), bioAffinity Technologies (NASDAQ:BIAF), Profound Medical (NASDAQ:PROF), Wolfspeed (NYSE: WOLF) and Sunshine Biopharma (NASDAQ:SBFM).
24-7 Market News
More News
Sunshine Biopharma Drops $6 Million Public Offering
Sunshine Biopharma Inc. (NASDAQ:SBFM) announced pricing of a $6.0 million public offering, which expected to close tomorrow, subject to customary conditions. The financing is structured around 10.9 million common units or pre-funded units, with each unit carrying two Series D warrants. The warrants are immediately exercisable, have an initial exercise price of $0.66 and expire five years after issuance.
24-7 Market News
Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know
Sunshine Biopharma, Inc. (SBFM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies
Sunshine Biopharma advances its lead coronavirus drug candidate into IND-enabling studies after strong preclinical results in animal models.read more...
Benzinga
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology   New York, NY – August 26, 2026 – Market News Updates News Commentary – If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of […] The post A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity appeared first on Financial News Media.
Financial News Media
EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancer
Sunshine Biopharma outlines K1.1 mRNA pipeline updates, advancing dual oncology therapy to target cold tumors in liver and lung cancer.read more...
Benzinga
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug
Sunshine Biopharma secures Canadian regulatory approval for generic Enalapril tablets to treat high blood pressure by 2026.read more...
Benzinga
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval
Sunshine Biopharma secures Canadian approval for its generic 2mg Dienogest tablets, expanding into women's health.read more...
Benzinga
Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today
Sunshine Biopharma stock fell after hours after the company announced a 1-for-10 reverse stock split to maintain Nasdaq listing compliance.read more...
Benzinga
Innovation Igniting into High-Growth Spotlight
As capital continues flowing into high-growth sectors tied to artificial intelligence, biotechnology, diagnostics, and defense technology, several emerging companies are rapidly capturing investor attention through financings, acquisitions, regulatory approvals, and platform expansion strategies. $SBFM, $TGNT, $CODX, $JUNS, $VIDA, $QUCY, $GFS, $GOOG, $MSFT, $NVDA
24-7 Market News

Advertisement|Remove ads.